ChemSpider 2D Image | Mirodenafil (hydrochloride) | C26H39Cl2N5O5S

Mirodenafil (hydrochloride)

  • Molecular FormulaC26H39Cl2N5O5S
  • Average mass604.589 Da
  • Monoisotopic mass603.204895 Da
  • ChemSpider ID29787534

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

4H-Pyrrolo[3,2-d]pyrimidin-4-one, 5-ethyl-3,5-dihydro-2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-7-propyl-, hydrochloride (1:2) [ACD/Index Name]
5-Ethyl-2-(5-{[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl}-2-propoxyphenyl)-7-propyl-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-ondihydrochlorid [German] [ACD/IUPAC Name]
5-Ethyl-2-(5-{[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl}-2-propoxyphenyl)-7-propyl-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one dihydrochloride [ACD/IUPAC Name]
5-Éthyl-2-(5-{[4-(2-hydroxyéthyl)-1-pipérazinyl]sulfonyl}-2-propoxyphényl)-7-propyl-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one, dichlorhydrate [French] [ACD/IUPAC Name]
5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one dihydrochloride
862189-96-6 [RN]
Mirodenafil (hydrochloride)
Mirodenafil dihydrochloride
4-[[3-(5-Ethyl-4,5-dihydro-4-oxo-7-propyl-1H-pyrrolo[3,2-d]pyrimidin-2-yl)-4-propoxyphenyl]sulfonyl]-1-piperazineethanol, dihydrochloride
5-ethyl-2-(5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one dihydrochloride
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

NL7L8TWT8Y [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      Metabolic Enzyme/Protease; MedChem Express HY-14930A
      Mirodenafil 2Hcl(SK3530 2Hcl) is a phosphodiesterase type 5 (PDE-5) inhibitor developed for the treatment of erectile dysfunction. MedChem Express
      Mirodenafil 2Hcl(SK3530 2Hcl) is a phosphodiesterase type 5 (PDE-5) inhibitor developed for the treatment of erectile dysfunction.; Target: PDE5; Mirodenafil is a newly developed oral phosphodiesterase type 5 inhibitor. MedChem Express HY-14930A
      Mirodenafil 2Hcl(SK3530 2Hcl) is a phosphodiesterase type 5 (PDE-5) inhibitor developed for the treatment of erectile dysfunction.;Target: PDE5Mirodenafil is a newly developed oral phosphodiesterase type 5 inhibitor. Mirodenafil, in doses of 50 or 100 mg, significantly improved erectile function and were well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities [1]. The concurrent administration of mirodenafil with alcohol was not associated with clinically significant hemodynamic changes in these healthy male volunteers in Korea. The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil administered with alcohol had a tolerability profile comparable to that of mirodenafil alone [2]. In these healthy Korean male volunteers, the coadministration of ketoconazole and rifampicin resulted in significant changes in systemic exposure to mirodenafil [3]. MedChem Express HY-14930A
      Others MedChem Express HY-14930A
      PDE MedChem Express HY-14930A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement